Skip to main content

Clinical & Experimental Metastasis

Ausgabe 4/2016

Inhalt (7 Artikel)

Open Access Research Paper

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

N. R. Sluiter, E. M. V. de Cuba, R. Kwakman, W. J. H. J. Meijerink, P. M. Delis-van Diemen, V. M. H. Coupé, J. A. M. Beliën, G. A. Meijer, I. H. J. T. de Hingh, E. A. te Velde

Open Access Research Paper

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases

Annalen Bleckmann, Lena-Christin Conradi, Kerstin Menck, Nadine Annette Schmick, Antonia Schubert, Eva Rietkötter, Jetcy Arackal, Peter Middel, Alexandra Schambony, Torsten Liersch, Kia Homayounfar, Tim Beißbarth, Florian Klemm, Claudia Binder, Tobias Pukrop

Research Paper

Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer

Maija P. Valta, Hongjuan Zhao, Matthias Saar, Johanna Tuomela, Rosalie Nolley, Johannes Linxweiler, Jouko Sandholm, Jaakko Lehtimäki, Pirkko Härkönen, Ilsa Coleman, Peter S. Nelson, Eva Corey, Donna M. Peehl

Research Paper

Metformin may protect nondiabetic breast cancer women from metastasis

Sahar Mohammed EL-Haggar, Nagla A. El-Shitany, Mohamed Farouk Mostafa, Noha Ahmed El-Bassiouny

Open Access Research Paper

MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively

Youguang Pu, Fangfang Zhao, Wenjing Cai, Xianghui Meng, Yinpeng Li, Shanbao Cai

Research Paper

Characterization of passive permeability at the blood–tumor barrier in five preclinical models of brain metastases of breast cancer

Chris E. Adkins, Afroz S. Mohammad, Tori B. Terrell-Hall, Emma L. Dolan, Neal Shah, Emily Sechrest, Jessica Griffith, Paul R. Lockman

Research Paper

Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion

Esha T. Shah, Akanksha Upadhyaya, Lisa K. Philp, Tiffany Tang, Dubravka Skalamera, Jennifer Gunter, Colleen C. Nelson, Elizabeth D. Williams, Brett G. Hollier

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.